Back to RU Rubric Capital Management LP

ATRSATRS

7 quarters

Position history for RURubric Capital Management LP's holdings in ANTARES PHARMA INC

As of its Q1 2022 13F, Rubric Capital Management held 10,900,000 shares of ATRS (Antares Pharma), worth $44.7M. Rubric Capital Management's 13F filings listed ATRS from Q4 2020 to Q1 2022, 6 quarterly filings. ATRS was 1.6% of Rubric Capital Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$14.2M

Total Shares Change

-3.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2022-Q1
Increased
10.9M
+0.9%
$44.7M1.6%—
46
2021-Q4
Increased
10.8M
+8.0%
$38.6M1.8%—
50
2021-Q3
Increased
10M
+5.3%
$36.4M1.0%—
48
2021-Q2
Increased
9.5M
+8.9%
$41.4M2.6%—
54
2021-Q1
Increased
8.7M
+144.3%
$35.9M2.1%—
80
2020-Q4
New
3.6M
—
$14.2M1.0%—
64

Optional analytics helps us improve. How it’s used